Effect of Inhaled Corticosteroids on Respiratory Function Tests and Airway Inflammation in Stable Chronic Obstructive Pulmonary Disease: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial

By Mirici A.  

Clinical Drug Investigation, Vol. 21, Iss. 12, 2001-12 ,pp. : 835-842

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives

By Mittmann Nicole  

PharmacoEconomics, Vol. 29, Iss. 5, 2011-05 ,pp. : 403-414

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Double-Blind, Randomised, Placebo-Controlled, Multicentre Study

By Murphy K.R.  

Clinical Drug Investigation, Vol. 20, Iss. 5, 2000-11 ,pp. : 337-349

Adis International

Access to resources Recommend Favorite

A 1-Year Prospective Cost-Effectiveness Analysis of Roflumilast for the Treatment of Patients with Severe Chronic Obstructive Pulmonary Disease

By Mölken Maureen P.M.H. Rutten-van  

PharmacoEconomics, Vol. 25, Iss. 8, 2007-01 ,pp. : 695-711

Adis International

Access to resources Recommend Favorite

Benefits and Risks of Pharmacological Smoking Cessation Therapies in Chronic Obstructive Pulmonary Disease

By Wagena E.J.  

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 381-403

Adis International

Access to resources Recommend Favorite